Log In
BCIQ
Print this Print this
 

NP202

  Manage Alerts
Collapse Summary General Information
Company Teva Pharmaceutical Industries Ltd.
DescriptionRisperidone implant based on LAD technology
Molecular Target Dopamine D2 receptor ; Serotonin (5-HT2) receptor
Mechanism of ActionDopamine D2 receptor antagonist; Serotonin (5-HT) receptor antagonist
Therapeutic ModalityMedical Devices: Drug/device combination

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today